Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance: Page 2
Agilent to sell Resolution Bioscience to Exact Sciences
Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.
September 12, 2023
Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology
Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.
September 6, 2023
LabGenomics USA acquires QDx Pathology
In a strategic move to expand its North American market, LabGenomics USA, a subsidiary of South Korea-based LabGenomics, has acquired diagnostic and molecular service provider QDx Pathology.
September 6, 2023
Ga. lab owner sentenced for $463M Medicare testing fraud scheme
Ga. lab owner Minal Patel was sentenced to serve 27 years in prison following his December 2022 conviction for his role in a $463 million Medicare fraud scheme.
September 8, 2023
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Ginkgo Bioworks, Google Cloud to collaborate on AI tools
Ginkgo Bioworks and Google Cloud have entered into a strategic five-year strategic partnership to develop artificial intelligence (AI) tools for biology and biosecurity.
September 6, 2023
Oxford Nanopore, IQVIA form nanopore sequencing partnership
Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.
August 31, 2023
Danaher to acquire Abcam for $5.7B
Science and medical technology firm Danaher announced Monday that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays.
August 29, 2023
CrisprBits, MolBio Diagnostics to collaborate on POC tests
The collaboration will leverage CrisprBits’ expertise in biotechnology and MolBio’s translation, manufacturing, and distribution abilities to build POC tests that detect pathogens and genetic markers.
August 23, 2023
Viome Life Sciences raises $86.5M in Series C financing round
This round brings Viome's total financing to $175 million, the firm said. A previous Series C financing round in October raised $67 million.
August 21, 2023
Agilent closes $550M liquid biopsy unit after failing to find path to profits
When Agilent bought Resolution, it identified the company’s presence in fast-growing NGS technologies for precision oncology as a way to expand its addressable market; rather than realizing that opportunity, Agilent has ended up cutting its losses.
August 18, 2023
Visiopharm, Boston Cell Standards team up to support higher assay requirements
If the higher standards are enforced, the collaboration could help enable a revised approach to the regulation of IHC that is intended to increase standardization through the use of modern clinical laboratory quality assurance protocols.
August 17, 2023
Previous Page
Page 2 of 123
Next Page